Oxidized low-density lipoproteins inhibit trophoblastic cell invasion. 2004

Laetitia Pavan, and Vassilis Tsatsaris, and Axelle Hermouet, and Patrice Therond, and Daniele Evain-Brion, and Thierry Fournier
INSERM U427, Faculté des Sciences Pharmaceutiques et Biologiques, Université René Descartes, Paris 5, 75006 Paris, France.

Human implantation involves a major invasion of the uterine wall and remodeling of the uterine arteries by trophoblastic cells. Abnormalities in these early steps of placental development lead to poor placentation, fetal growth defects and are frequently associated with pre-eclampsia, a serious disease specific to human pregnancy. Lipid metabolism is altered during human pregnancy, with low-density lipoproteins (LDL) becoming more susceptible to oxidation. The aim of this study was to localize oxidized LDL (oxLDL) at the implantation site and to investigate the role of oxLDL in human trophoblast invasion in vitro. We showed by immunohistochemistry that oxLDL was present in cytotrophoblasts of villous and extravillous origin in sections of first trimester human placenta. We purified primary invasive extravillous cytotrophoblasts isolated from the chorionic villi of human first trimester placenta and cultured them on Matrigel-coated transwells. We demonstrated using this invasion assay that oxLDL, but not native LDL, inhibited cell invasion in a concentration-dependent manner. These results suggest that human trophoblast invasion may be modulated by oxLDL in vivo and provide new insights into the pathophysiology of pre-eclampsia associated with oxidative stress and defective trophoblast invasion.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D010064 Embryo Implantation Endometrial implantation of EMBRYO, MAMMALIAN at the BLASTOCYST stage. Blastocyst Implantation,Decidual Cell Reaction,Implantation, Blastocyst,Nidation,Ovum Implantation,Blastocyst Implantations,Decidual Cell Reactions,Embryo Implantations,Implantation, Embryo,Implantation, Ovum,Implantations, Blastocyst,Implantations, Embryo,Implantations, Ovum,Nidations,Ovum Implantations
D010920 Placenta A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES). Placentoma, Normal,Placentome,Placentas,Placentomes
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011261 Pregnancy Trimester, First The beginning third of a human PREGNANCY, from the first day of the last normal menstrual period (MENSTRUATION) through the completion of 14 weeks (98 days) of gestation. Early Placental Phase,Pregnancy, First Trimester,Trimester, First,Early Placental Phases,First Pregnancy Trimester,First Pregnancy Trimesters,First Trimester,First Trimester Pregnancies,First Trimester Pregnancy,First Trimesters,Phase, Early Placental,Phases, Early Placental,Placental Phase, Early,Placental Phases, Early,Pregnancies, First Trimester,Pregnancy Trimesters, First,Trimesters, First
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014327 Trophoblasts Cells lining the outside of the BLASTOCYST. After binding to the ENDOMETRIUM, trophoblasts develop into two distinct layers, an inner layer of mononuclear cytotrophoblasts and an outer layer of continuous multinuclear cytoplasm, the syncytiotrophoblasts, which form the early fetal-maternal interface (PLACENTA). Cytotrophoblasts,Syncytiotrophoblasts,Trophoblast,Cytotrophoblast,Syncytiotrophoblast

Related Publications

Laetitia Pavan, and Vassilis Tsatsaris, and Axelle Hermouet, and Patrice Therond, and Daniele Evain-Brion, and Thierry Fournier
January 2000, Circulation,
Laetitia Pavan, and Vassilis Tsatsaris, and Axelle Hermouet, and Patrice Therond, and Daniele Evain-Brion, and Thierry Fournier
January 1999, The Journal of clinical investigation,
Laetitia Pavan, and Vassilis Tsatsaris, and Axelle Hermouet, and Patrice Therond, and Daniele Evain-Brion, and Thierry Fournier
November 1996, Kidney international,
Laetitia Pavan, and Vassilis Tsatsaris, and Axelle Hermouet, and Patrice Therond, and Daniele Evain-Brion, and Thierry Fournier
January 2015, Gastroenterology research and practice,
Laetitia Pavan, and Vassilis Tsatsaris, and Axelle Hermouet, and Patrice Therond, and Daniele Evain-Brion, and Thierry Fournier
August 1999, Clinica chimica acta; international journal of clinical chemistry,
Laetitia Pavan, and Vassilis Tsatsaris, and Axelle Hermouet, and Patrice Therond, and Daniele Evain-Brion, and Thierry Fournier
January 2008, Cardiology,
Laetitia Pavan, and Vassilis Tsatsaris, and Axelle Hermouet, and Patrice Therond, and Daniele Evain-Brion, and Thierry Fournier
July 2004, Rheumatology international,
Laetitia Pavan, and Vassilis Tsatsaris, and Axelle Hermouet, and Patrice Therond, and Daniele Evain-Brion, and Thierry Fournier
September 1996, Zhongguo yao li xue bao = Acta pharmacologica Sinica,
Laetitia Pavan, and Vassilis Tsatsaris, and Axelle Hermouet, and Patrice Therond, and Daniele Evain-Brion, and Thierry Fournier
July 1990, The Journal of clinical investigation,
Laetitia Pavan, and Vassilis Tsatsaris, and Axelle Hermouet, and Patrice Therond, and Daniele Evain-Brion, and Thierry Fournier
October 1996, Journal of autonomic pharmacology,
Copied contents to your clipboard!